Lethal Human H5N1 Influenza Virus Replikin Gene Still U...(nza pandemics and epidemics of the last ...)

Date:12/11/2007

nza pandemics and epidemics of the last century, for which the replikin count had been elevated before and during those outbreaks, decrease in the strain-specific replikin count which was causing the outbreak gave advance notice that the outbreak was over. For H5N1 influenza, each of the onsets and cessations of the outbreaks from 1997 to the present were correctly predicted by the replikin count. In 2006 a drop in the number of human H5N1 cases gave rise to optimism that the H5N1 human outbreak might be over; the replikin counts rose at that point, however, and the outbreak has continued. In addition, comparison of replikin counts for virus specimens in several countries showed that the highest counts were in Indonesia. In 2006 Replikins also announced its prediction that the percent mortality in humans due to this virus, rather than declining, would in fact increase, and that the first country in which this would occur would be Indonesia. In 2007, both of these predictions made in 2006 were shown to be correct.

The current persistence of the upregulation of the H5N1 replikin peak gene in Indonesia, and its additional increase in China, support continuing efforts to organize public health measures and to prepare appropriate anti-viral drugs and vaccines.

Detailed data from these studies are published in issued and pending patents. FluForecast(R) is a product and service of Replikins Ltd. and Replikins, LLC, 38 The Fenway, Boston MA 02215. See also http://www.replikins.com. Contact: sbogoch@replikins.com; Tel. 646-320-5910; 617-536-0220.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

'/>"/>

SOURCE Replikins Ltd. Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2
Related biology technology :

1. Massive reanalysis of genome data solves case of the lethal genes
2. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
3. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
4. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
5. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
6. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
10. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference